PATIENTSKY GRP NK-13736
CodeLab Capital AS provides cloud solutions for health professionals in Norway and internationally. It offers software development tools. The company was formerly known as PatientSky Group AS. The company was founded in 2014 and is headquartered in Oslo, Norway.
PATIENTSKY GRP NK-13736 (P99) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, PATIENTSKY GRP NK-13736 (P99) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
PATIENTSKY GRP NK-13736 - Net Assets Trend (None–None)
This chart illustrates how PATIENTSKY GRP NK-13736's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PATIENTSKY GRP NK-13736 (None–None)
The table below shows the annual net assets of PATIENTSKY GRP NK-13736 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to PATIENTSKY GRP NK-13736's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
PATIENTSKY GRP NK-13736 Competitors by Market Cap
The table below lists competitors of PATIENTSKY GRP NK-13736 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
IGTI11F
SA:IGTI11F
|
$42.35K |
|
SINOTRUK HONG KONG (4SK.SG)
STU:4SK
|
$42.37K |
|
Heungkuk Fire & Marine Insurance Co. Ltd. Pfd. Series 1
KQ:000545
|
$42.39K |
|
BCHQ39
SA:BCHQ39
|
$42.40K |
|
Goldstar Minerals Inc
PINK:GDMIF
|
$42.27K |
|
Zenergy AB (publ)
F:8T40
|
$42.23K |
|
Quest For Growth - Pricaf
BR:QFG
|
$42.21K |
|
RAYMOND REALTY LTD
NSE:RAYMONDREL
|
$42.21K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PATIENTSKY GRP NK-13736's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares PATIENTSKY GRP NK-13736's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently PATIENTSKY GRP NK-13736 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares PATIENTSKY GRP NK-13736's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PATIENTSKY GRP NK-13736 (P99) | €- | N/A | N/A | $42.30K |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $631.00 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $371.65K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.71 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.75 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.89 Million |